DK0916671T3 - Metalloprotease-inhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætniger indeholdende sådanne inhibitorer - Google Patents

Metalloprotease-inhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætniger indeholdende sådanne inhibitorer

Info

Publication number
DK0916671T3
DK0916671T3 DK98402806T DK98402806T DK0916671T3 DK 0916671 T3 DK0916671 T3 DK 0916671T3 DK 98402806 T DK98402806 T DK 98402806T DK 98402806 T DK98402806 T DK 98402806T DK 0916671 T3 DK0916671 T3 DK 0916671T3
Authority
DK
Denmark
Prior art keywords
inhibitors
alkyl
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK98402806T
Other languages
English (en)
Inventor
Nanteuil Guillaume De
Georges Remond
Joseph Paladino
Ghanem Atassi
Alain Pierre
Gordon Tucker
Jacqueline Bonnet
Massimo Sabatini
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0916671T3 publication Critical patent/DK0916671T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98402806T 1997-11-14 1998-11-13 Metalloprotease-inhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætniger indeholdende sådanne inhibitorer DK0916671T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714278A FR2771095B1 (fr) 1997-11-14 1997-11-14 Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0916671T3 true DK0916671T3 (da) 2002-03-25

Family

ID=9513364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98402806T DK0916671T3 (da) 1997-11-14 1998-11-13 Metalloprotease-inhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætniger indeholdende sådanne inhibitorer

Country Status (18)

Country Link
US (1) US6066633A (da)
EP (1) EP0916671B1 (da)
JP (1) JPH11209378A (da)
CN (1) CN1217332A (da)
AT (1) ATE212634T1 (da)
AU (1) AU740313B2 (da)
BR (1) BR9805014A (da)
CA (1) CA2254152C (da)
DE (1) DE69803648T2 (da)
DK (1) DK0916671T3 (da)
ES (1) ES2172101T3 (da)
FR (1) FR2771095B1 (da)
HU (1) HUP9802645A3 (da)
NO (1) NO311723B1 (da)
NZ (1) NZ332803A (da)
PL (1) PL329674A1 (da)
PT (1) PT916671E (da)
ZA (1) ZA9810411B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821842B1 (fr) * 2001-03-07 2003-05-09 Servier Lab Nouveaux derives d'inhibiteurs de mettalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
ITMI20071163A1 (it) * 2007-06-08 2008-12-09 C4T S C A R L Arilsolfonammidi dela beta-carbolina metodo per prepararle e composizione che le comprende
TWI443098B (zh) 2008-03-24 2014-07-01 Medivation Technologies Inc 吡啶并〔３，４－ｂ〕吲哚及使用方法
CN101597289B (zh) * 2008-06-02 2011-09-21 首都医科大学 2-色氨酰-β-四氢咔啉-3-甲酰基氨基酸苄酯及其制备方法和应用
WO2011038162A1 (en) * 2009-09-23 2011-03-31 Medivation Technologies, Inc. Pyrido(3,4-b)indoles and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
BR9611479B1 (pt) * 1995-11-13 2009-01-13 Ácidos alfa-iminoidroxÂmicos e carboxÍlicos n-substituÍdos cÍclicos e heterocÍclicos.
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO311723B1 (no) 2002-01-14
CN1217332A (zh) 1999-05-26
ATE212634T1 (de) 2002-02-15
CA2254152A1 (fr) 1999-05-14
DE69803648T2 (de) 2002-10-31
EP0916671A1 (fr) 1999-05-19
JPH11209378A (ja) 1999-08-03
NO985239D0 (no) 1998-11-10
NO985239L (no) 1999-05-18
ZA9810411B (en) 1999-05-24
DE69803648D1 (de) 2002-03-14
FR2771095B1 (fr) 1999-12-17
PT916671E (pt) 2002-06-28
BR9805014A (pt) 2001-04-24
AU740313B2 (en) 2001-11-01
PL329674A1 (en) 1999-05-24
CA2254152C (fr) 2003-04-08
AU9237798A (en) 1999-06-03
ES2172101T3 (es) 2002-09-16
HUP9802645A2 (hu) 1999-07-28
NZ332803A (en) 1999-05-28
HU9802645D0 (en) 1999-01-28
FR2771095A1 (fr) 1999-05-21
HUP9802645A3 (en) 2000-01-28
US6066633A (en) 2000-05-23
EP0916671B1 (fr) 2002-01-30

Similar Documents

Publication Publication Date Title
NO305988B1 (no) Nye pyridinforbindelser og farmasoeytiske sammensetninger som inneholder dem
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
GR3033996T3 (en) 3-(Piperi-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them
HU9202265D0 (en) Wall-mounted disc for joining sanitary equipments onto mounting wall
MY131193A (en) 7-(2-aminoethyl)-benzothiazolones
IE892189L (en) Derivatives of (aza) naphthalenesultam, their preparation¹and compositions containing them
EP0924207A4 (en) CHROMENE-3-CARBOXYLATE DERIVATIVES
GR3018194T3 (en) 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine.
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
DK0916671T3 (da) Metalloprotease-inhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætniger indeholdende sådanne inhibitorer
NO995638D0 (no) Heterobicykliske forbindelser til fremstilling av pyridonkarboksylsyrederivater
DK0379412T3 (da) Derivater af 1,8-benzonaphthyridin, fremstilling af disse forbindelser og midler, som indeholder forbindelserne
HUP0303457A2 (hu) Antimikrobiális hatású 2-piridonok, ezeket tartalmazó készítmények és alkalmazásuk
HUP0000966A2 (hu) Izoflavonszármazékok és ilyen vegyületeket hatóanyagként tartalmazó gyógyszerkészítmények
DK1061081T3 (da) Nye afledede af 7-oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridinecarboxylat, fremgangsmåder til fremstilling heraf og farmaceutiske tilberedninger, som indeholder disse
ES2192827T3 (es) Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
HUP9903319A3 (en) 2-hetaroylcyclohexane-1,3-dione derivatives, use thereof and herbicide compositions containing these compounds